The Hope and Hype of Precision Medicine: A Health Policy and Bioethics Consortium

Description

There has been considerable hype surrounding personalized and precision medicine in the past few years-including President Obama's 2015 announcement of $215 million for the Precision Medicine Initiative. While some policymakers hail this movement as a pending revolution in healthcare, other commentators are skeptical, arguing that the same funding directed toward the social and behavioral determinants of health would yield far greater gains in terms of patient benefits and healthcare savings.

How important is precision medicine for our healthcare marketplace, and what should the expected outcomes be for public investment in research in this area?

This event was free and open to the public.

Speakers

Sandro Galea, MD, MPH, DrPH, Dean and Robert A. Knox Professor, Boston University School of Public Health